Experience of a single center in the treatment of rare malignant peripheral nerve sheath tumors during the years 1991–2021

References

• Sharma S, Shah J, Bali H. Malignant peripheral nerve sheath tumor: a rare malignancy. J Oral Maxillofac Pathol. 2020;24(4):86.
   Google Scholar
• Farid M, Demicco E, Garcia R, et al. Malignant peripheral nerve sheath tumors. Oncologist. 2014;19(2):193–201.
   PubMed Web of Science ®Google Scholar
• Ogawa B, Skaggs D, Kay R. Malignant peripheral nerve sheath tumor of the lumbar spine. Am J Orthoped. 2009;38:89–92.
   Google Scholar
• Ducatman B, Scheithauer B, Piepgras D, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57(10):2006–2021.
   PubMed Web of Science ®Google Scholar
• Anghileri M, Miceli R, Fiore M, et al. Malignant peripheral nerve sheath tumors. Cancer. 2006;107(5):1065–1074.
   PubMed Web of Science ®Google Scholar
• Watson K, Al Sannaa G, Kivlin C, et al. Patterns of recurrence and survival in sporadic, neurofibromatosis type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017;126(1):319–329.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Malignant peripheral nerve sheath tumor. National Cancer Institute [Internet]. 2020 [cited 2022 Jan 26]. Available from: https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst
   Google Scholar
• Gladdy R, Qin L, Moraco N, et al. Do Radiation-Associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28(12):2064–2069.
   PubMed Web of Science ®Google Scholar
• Korf B. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5(6):477–485.
   PubMedGoogle Scholar
• Geller D, Gebhardt M. MPNST: diagnosis, treatment, prognosis and research [Internet]. Liddy Shriver Sarcoma Initiat; 2016 [cited 2021 Dec 7]. Available from: http://sarcomahelp.org/mpnst.html
   Google Scholar
• Collin C, Godbold J, Hajdu S, et al. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987;5(4):601–612.
   PubMed Web of Science ®Google Scholar
• Smolle M, Andreou D, Tunn P, et al. Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk. EFORT Open Rev. 2017;2(10):421–431.
   PubMed Web of Science ®Google Scholar
• Arifi S, Belbaraka R, Rahhali R, et al. Treatment of adult soft tissue sarcomas: an overview. Rare Cancers Ther. 2015;3:69–87.
   PubMedGoogle Scholar
• Scandinavian Sarcoma Group [Internet]. 2021 [cited 2021 Dec 15]. Available from: https://www.ssg-org.net/
   Google Scholar
• Zehou O, Fabre E, Zelek L, et al. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review. Orphanet J Rare Dis. 2013;8:127.
   PubMed Web of Science ®Google Scholar
• Kahn J, Gillespie A, Tsokos M, et al. Radiation therapy in management of sporadic and neurofibromatosis type 1-Associated malignant peripheral nerve sheath tumors. Front Oncol. 2014;4(324). doi:10.3389/fonc.2014.00324
   PubMedGoogle Scholar
• Trovik C, Bauer H, Styring E, et al. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta Orthop. 2017;88(3):341–347.
   PubMed Web of Science ®Google Scholar
• Enneking W, Spanier S, Goodman M. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106–120.
   PubMed Web of Science ®Google Scholar
• Hermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol. 1994;10(1):12–20.
   PubMed Web of Science ®Google Scholar
• Tukiainen E, Kantonen I, Koivisto-Korander R. Pehmytkudossarkoomien kirurginen hoito [Surgical treatment of soft tissue sarcomas]. Duodecim Laaketieteellinen Aikakauskirja. 2015;71:1247–1253.
   Google Scholar
• Sandy G, Shores J, Reeves M. Tikhoff-Linberg procedure and chest wall resection for recurrent sarcoma of the shoulder girdle involving the chest wall. J Surg Oncol. 2005;89(2):91–94.
   PubMed Web of Science ®Google Scholar
• Yang J, Chang A, Baker A, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203.
   PubMed Web of Science ®Google Scholar
• Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group. J Clin Oncol. 2005;23(33):8422–8430.
   PubMed Web of Science ®Google Scholar
• Kroep J, Ouali M, Gelderblom H, et al. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. Ann Oncol. 2011;22(1):207–214.
   PubMed Web of Science ®Google Scholar
• Wanebo J, Malik J, Vandenberg S, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer. 1993;71(4):1247–1253.
   PubMed Web of Science ®Google Scholar
• Stark A, Buhl R, Hugo H, et al. Malignant peripheral nerve sheath tumours – report of 8 cases and review of the literature. Acta Neurochir. 2001;143(4):357–364.
   PubMed Web of Science ®Google Scholar
• Goertz O, Langer S, Uthoff D, et al. Diagnosis, treatment and survival of 65 patients with malignant peripheral nerve sheath tumors. Anticancer Res. 2014;34(2):777–783.
   PubMed Web of Science ®Google Scholar
• Stucky C, Johnson k, Gray R, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012;19(3):878–885.
   PubMed Web of Science ®Google Scholar
• Porter D, Prasad V, Foster L, et al. Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma. 2009;2009:756395.
   PubMedGoogle Scholar
• Lazarev S, Demicco E, Gupta V. Prognostic factors for survival in resectable malignant peripheral nerve sheath tumors. Int J Radiat Oncol. 2017;99(2):E755.
   Web of Science ®Google Scholar
• Schwabe M, Spiridonov S, Yanik E, et al. How effective are noninvasive tests for diagnosing malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1? Diagnosing MPNST in NF1 patients. Sarcoma. 2019;2019:4627521–4627528.
   PubMedGoogle Scholar
• Park S, Sawitzki B, Kluwe L, et al. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med. 2013;11:109.
   PubMed Web of Science ®Google Scholar